Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
Al-Samkari H.
New England Journal of Medicine, 2026

Professor
İstinye Üniversitesi
Faculty of Medicine
Department of Internal Medicine
Search Publications
Records found: 127
0 active filters
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
Al-Samkari H.
New England Journal of Medicine, 2026
The Impact of Concurrent Proton Pump Inhibitors on Nivolumab Response in Metastatic Non-Small Cell Lung Cancer: A Multicenter Real-Life Study
Hendem E.
Medicina Lithuania, 2026
The Impact of Concurrent Proton Pump Inhibitors on Nivolumab Response in Metastatic Non-Small Cell Lung Cancer: A Multicenter Real-Life Study
Hendem, E
MEDICINA-LITHUANIA, 2026
Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program
Sendur M.A.N.
BMC Cancer, 2025
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC
Yildirim M.E.
Journal of Oncology Pharmacy Practice, 2025
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC
Yildirim, ME
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025
Superiority of Pathologic Lymph Node Ratio over Positive Lymph Node Count in Operated Early-Stage Breast Cancer
Urakçı Z.
Annali Italiani Di Chirurgia, 2024
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes
Ozbay M.F.
Cancers, 2024
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes
Ozbay, MF
CANCERS, 2024
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience
Majidova N.
Oncology Research and Treatment, 2024
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience
Majidova, N
ONCOLOGY RESEARCH AND TREATMENT, 2024
The Prognostic Role of Mismatch Repair Status and CDX-2 Expression with Inflammatory Markers and Pathological Risk Factors in Stage II and III Colon Cancer: Multicenter Real-Life Data
Aydin S.G.
Journal of Gastrointestinal Cancer, 2024
Page 1 / 11